Cipla Misses Profit Targets as US Market Weakness Weighs
Cipla failed to meet its profit targets, citing weakness in the US market; its shares declined.
Related stories
Bristol Myers Squibb Sees FY Adjusted Revenue at $49.75B-$50.25B
M impact | EARNINGS | Oct 29, 2026, 02:35 PM UTC
Zhongguangcun Science-Tech Leasing Net Profit Falls 14%
January-September 2026 net profit fell 14% year on year to RMB 184.34 million.
M impact | EARNINGS | Oct 29, 2026, 02:23 PM UTC
Seshaasai Technologies Reports September-Quarter Revenue of 4.05 Billion Rupees
M impact | EARNINGS | Oct 29, 2026, 02:22 PM UTC
Zhongguancun Science-Tech Leasing Reports 9M Revenue of RMB 589.6 Million
L impact | EARNINGS | Oct 29, 2026, 02:22 PM UTC
Luxshare Precision Expects FY2026 Net Profit of RMB19.09B–RMB19.92B
M impact | EARNINGS | Oct 29, 2026, 02:22 PM UTC
Seshaasai Technologies Reports Sept-Quarter Consolidated Profit of 697.3 Million Rupees
L impact | EARNINGS | Oct 29, 2026, 02:22 PM UTC